Neonatal Infections: Group B Streptococcus

Overview

Journal BMJ Clin Evid

Specialty General Medicine

Date 2014 Mar 4

PMID 24580886

Citations 19

Authors

Paul T Heath

Luke Anthony Jardine

Affiliations

Soon will be listed here.

Abstract

Introduction: One in four women carry group B streptococci vaginally, which can infect the amniotic fluid before delivery or can infect the baby during delivery, causing sepsis, pneumonia, or meningitis. Very low-birthweight infants are at much higher risk of infection or mortality, with up to 3% infected and mortality rates of up to 30%, even with immediate antibiotic treatment. Late-onset group B streptococcal infection begins from 7 days of age, and usually causes fever or meningitis, but is less often fatal compared with early infection.

Methods And Outcomes: We conducted a systematic review and aimed to answer the following clinical question: what are the effects of prophylactic treatment of asymptomatic neonates less than 7 days old with known risk factors for early-onset group B streptococcal infection? We searched: Medline, Embase, The Cochrane Library, and other important databases up to November 2013 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).

Results: We found 5 studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.

Conclusions: In this systematic review we present information relating to the effectiveness and safety of the following interventions: different antibiotics, monitoring and selective treatment, and routine antibiotic prophylaxis.

Citing Articles

Predicting outcomes with compounding comorbidities - Left-sided congenital diaphragmatic hernia complicated by pre-viable premature rupture of the membranes: A case report.

Landau K, Hardas G, Thomas G, Smet M Case Rep Womens Health. 2025; 45:e00680.

PMID: 39867720 PMC: 11760299. DOI: 10.1016/j.crwh.2025.e00680.

Comparative Genomic Analysis of Prophages in Human Vaginal Isolates of .

Wiafe-Kwakye C, Fournier A, Maurais H, Southworth K, Molloy S, Neely M Pathogens. 2024; 13(8).

PMID: 39204211 PMC: 11357604. DOI: 10.3390/pathogens13080610.

Editorial: Women in infectious agents and disease: 2023.

Khaiboullina S, Chen Z, Alva-Murillo N, Holban A Front Microbiol. 2024; 15:1436831.

PMID: 38946895 PMC: 11212011. DOI: 10.3389/fmicb.2024.1436831.

and induce distinct effector γδ T cell responses during neonatal sepsis.

Witt L, Greenfield K, Knoop K iScience. 2024; 27(5):109669.

PMID: 38646164 PMC: 11033170. DOI: 10.1016/j.isci.2024.109669.

Environmental Toxicant Exposure Paralyzes Human Placental Macrophage Responses to Microbial Threat.

Stephens V, Moore R, Spicer S, Talbert J, Lu J, Chinni R ACS Infect Dis. 2023; 9(12):2401-2408.

PMID: 37955242 PMC: 11380109. DOI: 10.1021/acsinfecdis.3c00490.

References

Libster R, Edwards K, Levent F, Edwards M, Rench M, Castagnini L . Long-term outcomes of group B streptococcal meningitis. Pediatrics. 2012; 130(1):e8-15. DOI: 10.1542/peds.2011-3453. View

Wolf R, Olinsky A . Prolonged rupture of fetal membranes and neonatal infections. S Afr Med J. 1976; 50(15):574-6. View

Zaleznik D, Rench M, Hillier S, Krohn M, Platt R, Lee M . Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. Clin Infect Dis. 2000; 30(2):276-81. DOI: 10.1086/313665. View

Knox J . Group B streptococcal infection: a review and update. Br J Vener Dis. 1979; 55(2):118-20. PMC: 1045604. DOI: 10.1136/sti.55.2.118. View

Woodgate P, Flenady V, Steer P . Intramuscular penicillin for the prevention of early onset group B streptococcal infection in newborn infants. Cochrane Database Syst Rev. 2004; (3):CD003667. PMC: 9029842. DOI: 10.1002/14651858.CD003667.pub2. View

Phares C, Lynfield R, Farley M, Mohle-Boetani J, Harrison L, Petit S . Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA. 2008; 299(17):2056-65. DOI: 10.1001/jama.299.17.2056. View

Heath P, Balfour G, Weisner A, Efstratiou A, Lamagni T, Tighe H . Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet. 2004; 363(9405):292-4. DOI: 10.1016/S0140-6736(03)15389-5. View

Bedford H, DE LOUVOIS J, Halket S, Peckham C, Hurley R, Harvey D . Meningitis in infancy in England and Wales: follow up at age 5 years. BMJ. 2001; 323(7312):533-6. PMC: 48156. DOI: 10.1136/bmj.323.7312.533. View

Chung M, Ko D, Chen C, Huang C, Chung C, Chen F . Neonatal group B streptococcal infection: a 7-year experience. Chang Gung Med J. 2004; 27(7):501-8. View

10.

Towers C, Carr M, Padilla G, Asrat T . Potential consequences of widespread antepartal use of ampicillin. Am J Obstet Gynecol. 1998; 179(4):879-83. DOI: 10.1016/s0002-9378(98)70182-6. View

11.

Benitz W, Gould J, Druzin M . Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics. 1999; 103(6):e77. DOI: 10.1542/peds.103.6.e77. View

12.

Bizzarro M, Dembry L, Baltimore R, Gallagher P . Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis. Pediatrics. 2008; 121(4):689-96. DOI: 10.1542/peds.2007-2171. View

13.

Law M, Palomaki G, Alfirevic Z, Gilbert R, Heath P, McCartney C . The prevention of neonatal group B streptococcal disease: a report by a working group of the Medical Screening Society. J Med Screen. 2005; 12(2):60-8. DOI: 10.1258/0969141053908366. View

14.

Schrag S, Zywicki S, Farley M, Reingold A, Harrison L, Lefkowitz L . Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000; 342(1):15-20. DOI: 10.1056/NEJM200001063420103. View

15.

Saez-Llorens X, Castano E, Cortes L, Torres A, Suarez M, Bissot A . Intrapartum prophylaxis with ceftriaxone decreases rates of bacterial colonization and early-onset infection in newborns. Clin Infect Dis. 1995; 21(4):876-80. DOI: 10.1093/clinids/21.4.876. View

16.

Ungerer R, Lincetto O, McGuire W, Saloojee H, Gulmezoglu A . Prophylactic versus selective antibiotics for term newborn infants of mothers with risk factors for neonatal infection. Cochrane Database Syst Rev. 2004; (4):CD003957. DOI: 10.1002/14651858.CD003957.pub2. View

17.

Weindling A, Hawkins J, Coombes M, Stringer J . Colonisation of babies and their families by group B streptococci. Br Med J (Clin Res Ed). 1981; 283(6305):1503-5. PMC: 1507901. DOI: 10.1136/bmj.283.6305.1503. View

18.

GOTOFF S, Boyer K . Prevention of early-onset neonatal group B streptococcal disease. Pediatrics. 1997; 99(6):866-9. DOI: 10.1542/peds.99.6.866. View

19.

Stoll B, Hansen N, Fanaroff A, Wright L, Carlo W, Ehrenkranz R . Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med. 2002; 347(4):240-7. DOI: 10.1056/NEJMoa012657. View

20.

Siegel J, McCracken Jr G, Threlkeld N, DePasse B, Rosenfeld C . Single-dose penicillin prophylaxis of neonatal group-B-streptococcal disease. Lancet. 1982; 1(8287):1426-30. DOI: 10.1016/s0140-6736(82)92449-7. View